Literature DB >> 23421771

P-selectin paradox and dementia of the Alzheimer type: circulating P-selectin is increased but platelet-bound P-selectin after agonist provocation is compromised.

Petter Järemo1, Micha Milovanovic, Caroline Buller, Staffan Nilsson, Bengt Winblad.   

Abstract

OBJECTIVE: Knowledge concerning the neurobiological importance of platelets in Alzheimer's disease (AD) is sparse. P-selectin, which is located together with β-amyloid precursor proteins in platelet α-granules, is also found in endothelial cells. Upon activation, P-selectin is relocated to cell surfaces where it acts as a receptor. Subsequently, the protein is cleaved from the membrane, to then be circulated. We investigated P-selectin behavior in AD dementia.
METHODS: We recruited 23 persons diagnosed moderate AD and 17 healthy elders without obvious memory problems. Circulating P-selectin was analyzed using an ELISA technique and flow cytometry was used to measure surface-bound P-selectin. The latter measure was carried out without provocation (platelet activity) and after in vitro agonist stimulation (platelet reactivity). A thrombin-receptor activating peptide (TRAP-6) (74 μmol/L)) was used as a platelet agonist.
RESULTS: Soluble P-selectin was augmented in AD (p = 0.019) but platelet membrane-attached P-selectin did not differ from controls. AD diagnosis was associated with less surface-bound P-selectin after provocation. Significant results were obtained when 74 μmol/L TRAP-6 was used as a platelet agonist (p = 0.0008).
CONCLUSION: This study describes apparently paradoxical P-selectin reactions in moderate AD. While soluble P-selectin was higher in the disease group, membrane-attached P-selectin without agonist stimulation was no different between the disease and control groups. In contrast, AD was linked to lower platelet reactivity. The current findings encourage further research into this P-selectin paradox and its relevance for AD and, perhaps, other types of dementia as well.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23421771     DOI: 10.3109/00365513.2013.764572

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  10 in total

1.  SELP genetic polymorphisms may contribute to the pathogenesis of coronary heart disease and myocardial infarction: a meta-analysis.

Authors:  Dong-Hui Zhou; Yong Wang; Wei-Na Hu; Li-Jie Wang; Qi Wang; Miao Chi; Yuan-Zhe Jin
Journal:  Mol Biol Rep       Date:  2014-02-07       Impact factor: 2.316

2.  ABO blood type, factor VIII, and incident cognitive impairment in the REGARDS cohort.

Authors:  Kristine S Alexander; Neil A Zakai; Sarah Gillett; Leslie A McClure; Virginia Wadley; Fred Unverzagt; Mary Cushman
Journal:  Neurology       Date:  2014-09-10       Impact factor: 9.910

Review 3.  Evidence of endothelial dysfunction in the development of Alzheimer's disease: Is Alzheimer's a vascular disorder?

Authors:  Rory J Kelleher; Roy L Soiza
Journal:  Am J Cardiovasc Dis       Date:  2013-11-01

4.  Platelets, gender and acute cerebral infarction.

Authors:  Petter Järemo; Marie Eriksson-Franzen; Micha Milovanovic
Journal:  J Transl Med       Date:  2015-08-16       Impact factor: 5.531

5.  Platelet dysfunction in hypercholesterolemia mice, two Alzheimer's disease mouse models and in human patients with Alzheimer's disease.

Authors:  Barbara Plagg; Josef Marksteiner; Kathrin M Kniewallner; Christian Humpel
Journal:  Biogerontology       Date:  2015-05-07       Impact factor: 4.277

6.  ABO Blood Group and Dementia Risk--A Scandinavian Record-Linkage Study.

Authors:  Senthil K Vasan; Klaus Rostgaard; Henrik Ullum; Mads Melbye; Henrik Hjalgrim; Gustaf Edgren
Journal:  PLoS One       Date:  2015-06-04       Impact factor: 3.240

Review 7.  Beyond Haemostasis and Thrombosis: Platelets in Depression and Its Co-Morbidities.

Authors:  Benedetta Izzi; Alfonsina Tirozzi; Chiara Cerletti; Maria Benedetta Donati; Giovanni de Gaetano; Marc F Hoylaerts; Licia Iacoviello; Alessandro Gialluisi
Journal:  Int J Mol Sci       Date:  2020-11-21       Impact factor: 5.923

Review 8.  Platelets, a reliable source for peripheral Alzheimer's disease biomarkers?

Authors:  Michael Veitinger; Balazs Varga; Sheila B Guterres; Maria Zellner
Journal:  Acta Neuropathol Commun       Date:  2014-06-16       Impact factor: 7.801

Review 9.  The blood-brain barrier in Alzheimer's disease.

Authors:  Elena Zenaro; Gennj Piacentino; Gabriela Constantin
Journal:  Neurobiol Dis       Date:  2016-07-15       Impact factor: 5.996

10.  Platelet biomarkers identifying mild cognitive impairment in type 2 diabetes patients.

Authors:  Haitao Yu; Yanchao Liu; Ting He; Yao Zhang; Jiahua He; Mengzhu Li; Bijun Jiang; Yang Gao; Chongyang Chen; Dan Ke; Jianjun Liu; Benrong He; Xifei Yang; Jian-Zhi Wang
Journal:  Aging Cell       Date:  2021-09-16       Impact factor: 9.304

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.